Insights

AI Health Intelligence Sema4 specializes in data-driven health insights using AI and machine learning on longitudinal clinical and genomic data, presenting a strong opportunity to offer enterprise analytics, predictive health modeling, and decision support services to healthcare providers and biopharma clients seeking advanced patient trajectory analytics.

Centrellis Platform Centrellis is a proprietary health intelligence platform that enables comprehensive disease and wellness understanding, suggesting upsell opportunities for platform licensing, customization, and integration with existing EHRs and data lakes for customers pursuing end-to-end health insights.

Patient-Centered Value Sema4 emphasizes patient partnership and data sharing for broad benefit, which aligns with value-based care initiatives and patient-centered outcomes research, offering potential collaborations with healthcare systems, payers, and advocacy groups focused on measurable health improvements.

AI Agent Growth Recent launches and Gartner recognitions for Sema4.ai indicate a growing portfolio in autonomous AI agents for enterprise work, opening cross-sell and integration opportunities with Sema4’s health data assets for knowledge work automation and decision support in life sciences and clinical operations.

Financial and Size Fit With a mid-market employee base and reported revenue in the tens of millions, Sema4 fits mid-sized health tech partnerships, suggesting opportunities with midsize health systems, regional hospitals, and specialty clinics that need scalable data platforms and AI-enabled insights without enterprise-tier pricing.

Similar companies to Sema4

Sema4 Tech Stack

Sema4 uses 6 technology products and services including Amazon Web Services, Bitly, Lever, and more. Explore Sema4's tech stack below.

  • Cloud Hosting
  • Bitly
    Marketing
  • Lever
    Recruitment Marketing
  • Google
    Search Engines
  • Google Hangouts
    Web Conferencing
  • Web Conferencing

Media & News

Sema4's Email Address Formats

Sema4 uses at least 5 email formats:
Sema4 Email FormatsExamplePercentage
First.Last@sema4.comJohn.Doe@sema4.com
98%
First.Middle@sema4.comJohn.Michael@sema4.com
2%
First.Last@sema4genomics.comJohn.Doe@sema4genomics.com
98%
LastFirst@sema4genomics.comDoeJohn@sema4genomics.com
1%
LF@sema4genomics.comDJ@sema4genomics.com
1%

Frequently Asked Questions

What is Sema4's stock symbol?

Minus sign iconPlus sign icon
Sema4 is a publicly traded company; the company's stock symbol is SMFRW.

How much revenue does Sema4 generate?

Minus sign iconPlus sign icon
As of October 2026, Sema4's annual revenue is estimated to be $50M - $100M.

What is Sema4's SIC code and NAICS code?

Minus sign iconPlus sign icon
Sema4's SIC code is 8731 - Commercial Physical and Biological Research and NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Sema4 have currently?

Minus sign iconPlus sign icon
As of October 2026, Sema4 has approximately 137 employees across 5 continents, including North America, Europe and Asia. Key team members include Chief Operating Officer: J. M., Chief Business Officer: K. S. and Chief People Officer: K. W. Explore Sema4's employee directory with LeadIQ.

What industry does Sema4 belong to?

Minus sign iconPlus sign icon
Sema4 operates in the Biotechnology Research industry.

What technology does Sema4 use?

Minus sign iconPlus sign icon
Sema4's tech stack includes Amazon Web Services, Bitly, Lever, Google, Google Hangouts and Zoom.

What is Sema4's email format?

Minus sign iconPlus sign icon
Sema4's email format typically follows the pattern of First.Last@sema4.com. Find more Sema4 email formats with LeadIQ.

When was Sema4 founded?

Minus sign iconPlus sign icon
Sema4 was founded in 2017.
Sema4 logo

Sema4

Biotechnology ResearchConnecticut, United States51-200 Employees

Sema4 is a biotechnology research company based in Stamford, Connecticut. It focuses on patient-centered health intelligence, applying artificial intelligence and machine learning to longitudinal clinical and genomic data to build dynamic models of health and individualized health trajectories. The company’s Centrellis health intelligence platform supports a more complete understanding of disease and wellness and informs science-driven solutions to pressing medical needs.

Operating at the intersection of biotechnology and data science, Sema4 aims to advance healthcare through data-driven insights while treating patients as partners and endorsing data sharing for the benefit of all. A notable recent development is the November 2024 announcement of the general availability of a full-stack AI agent platform from Sema4.ai, reflecting an expansion of its AI capabilities for enterprise work.

Section iconCompany Overview

SIC Code
8731 - Commercial Physical and Biological Research
Stock Symbol
SMFRW
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2017
Employees
51-200

Section iconFunding & Financials

  • $50M - $100M

    Sema4's revenue is estimated to be in the range of $50M - $100M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.